The phosphorylation of this receptor in different cancers is known to activate phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)-dependent pathways that participate in diverse signaling that promotes proliferation and resistance to chemotherapy [19]. The gene discussed is AKT1; the disease is cancer.